SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-151521
Filing Date
2024-05-31
Accepted
2024-05-31 14:00:58
Documents
2
Group Members
ALBERT CHADANIEL ESTESFHMLS X, L.L.C.FHMLS X, L.P.FHMLS XI, L.L.C.FHMLS XI, L.P.FHMLSP OVERAGE, L.L.C.FHMLSP OVERAGE, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.FRAZIER LIFE SCIENCES X, L.P.FRAZIER LIFE SCIENCES XI, L.P.J

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d798804dsc13da.htm SC 13D/A 397665
2 EX-99.A d798804dex99a.htm EX-99.A 28573
  Complete submission text file 0001193125-24-151521.txt   428423
Mailing Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304
Business Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304 650-325-5156
Frazier Life Sciences Public Fund, L.P. (Filed by) CIK: 0001863769 (see all company filings)

IRS No.: 862999645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Subject) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93640 | Film No.: 241008985
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)